InfuSystems Holdings Inc (INFU) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
InfuSystems Holdings Inc stock (INFU) is currently trading at $9.79. InfuSystems Holdings Inc PE ratio is 30.97. InfuSystems Holdings Inc PS ratio (Price-to-Sales) is 1.36. Analyst consensus price target for INFU is $14.90. WallStSmart rates INFU as Underperform.
- INFU PE ratio analysis and historical PE chart
- INFU PS ratio (Price-to-Sales) history and trend
- INFU intrinsic value — DCF, Graham Number, EPV models
- INFU stock price prediction 2025 2026 2027 2028 2029 2030
- INFU fair value vs current price
- INFU insider transactions and insider buying
- Is INFU undervalued or overvalued?
- InfuSystems Holdings Inc financial analysis — revenue, earnings, cash flow
- INFU Piotroski F-Score and Altman Z-Score
- INFU analyst price target and Smart Rating
InfuSystems Holdings Inc
📊 No data available
Try selecting a different time range
INFU Intrinsic Value Analysis for Value Investors
Benjamin Graham Formula · InfuSystems Holdings Inc (INFU)
INFU trades at a significant discount to its Graham intrinsic value of $14.51, offering a 48% margin of safety — a level value investors typically seek before buying.
Based on Benjamin Graham Formula. Growth rate capped at 25%. For informational purposes only. Not financial advice.
Smart Analysis
InfuSystems Holdings Inc (INFU) · 10 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in price/sales, eps growth, institutional own.. Concerns around market cap and operating margin. Fundamentals are solid but monitor weak areas for improvement.
InfuSystems Holdings Inc (INFU) Key Strengths (3)
Earnings per share surging 123.90% year-over-year
81.21% of shares held by major funds and institutions
Paying $1.36 for every $1 of annual revenue
Supporting Valuation Data
InfuSystems Holdings Inc (INFU) Areas to Watch (7)
Near-zero operating margins, business under pressure
Very thin margins, barely profitable
Micro-cap company with very limited liquidity and high volatility
Premium pricing at 3.2x book value
Modest revenue growth at 7.00%
Moderate profitability with room for improvement
Growth is fairly priced, not cheap, not expensive
Supporting Valuation Data
InfuSystems Holdings Inc (INFU) Detailed Analysis Report
Overall Assessment
This company scores 53/100 in our Smart Analysis, earning a C- grade. Out of 10 metrics analyzed, 3 register as strengths (avg 9.3/10) while 7 fall into concern territory (avg 3.6/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on EPS Growth, Institutional Own., Price/Sales. Valuation metrics including Price/Sales (1.36) suggest the stock is attractively priced. Growth metrics are encouraging with EPS Growth at 123.90%.
The Bear Case
The primary concerns are Operating Margin, Profit Margin, Market Cap. Some valuation metrics including PEG Ratio (1.73), Price/Book (3.21) suggest expensive pricing. Growth concerns include Revenue Growth at 7.00%, which may limit upside. Profitability pressure is visible in Return on Equity at 11.50%, Operating Margin at 4.73%, Profit Margin at 4.62%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Operating Margin improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at 11.50% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at 7.00% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a moderate-to-high risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Mixed fundamentals with both positives (EPS Growth, Institutional Own.) and negatives (Operating Margin, Profit Margin). A cautious approach is warranted. Monitor for improvement in weak areas before increasing conviction.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
INFU Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
INFU's Price-to-Sales ratio of 1.36x trades 22% below its historical average of 1.75x (62th percentile). The current valuation is 88% below its historical high of 11.74x set in Jan 2008, and 240% above its historical low of 0.4x in Oct 2011. Over the past 12 months, the PS ratio has expanded from ~0.8x, reflecting growing market expectations outpacing revenue growth.
WallStSmart Analysis Synopsis
Data-driven financial summary for InfuSystems Holdings Inc (INFU) · HEALTHCARE › MEDICAL DEVICES
The Big Picture
InfuSystems Holdings Inc operates as a stable business with moderate growth and solid fundamentals. Revenue reached 143M with 7% growth year-over-year. Profit margins are thin at 4.6%, typical for companies in this phase that are reinvesting heavily in growth.
Key Findings
Generating 7M in free cash flow and 7M in operating cash flow. Earnings are translating into actual cash generation.
What to Watch Next
Margin expansion: can InfuSystems Holdings Inc push profit margins above 15% as the business scales?
Volatility is elevated with a beta of 1.63, so expect amplified moves relative to the broader market.
Sector dynamics: monitor MEDICAL DEVICES industry trends, competitive moves, and regulatory changes that could impact InfuSystems Holdings Inc.
Bottom Line
InfuSystems Holdings Inc offers stability with moderate growth and solid fundamentals. The valuation may present an opportunity for patient investors, though limited growth means returns will likely come from dividends and modest capital appreciation rather than explosive gains.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions(1 last 3 months)
| Insider | Type | Shares |
|---|---|---|
STEELE, BARRY G Executive VP and CFO | Buy | +2,064 |
Data sourced from SEC Form 4 filings
Last updated: 11:32:36 AM
About InfuSystems Holdings Inc(INFU)
NYSE MKT
HEALTHCARE
MEDICAL DEVICES
USA
InfuSystem Holdings, Inc., provides infusion pumps and related products and services in the United States and Canada. The company is headquartered in Rochester Hills, Michigan.